Physician profile
Daria B Terrell
NPI 1477532364
$2,848.78
in general payments reported to CMS, 2019-2025
21 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $92.82 · 2021: $360 · 2022: $321 · 2023: $408 · 2024: $423 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $644.66 | 2019-2024 | Grafix Pl, Collagenase Santyl, Oasis |
| Amgen INC. | $573.62 | 2019-2025 | Evenity, Prolia |
| Organogenesis INC. | $279.91 | 2021-2025 | Apligraf, Puraply |
| Radius Health, INC. | $190.25 | 2019 | |
| Stryker Corporation | $135.53 | 2019-2021 | |
| Convatec INC. | $129.00 | 2019 | |
| Kerecis Limited | $124.91 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ferring Pharmaceuticals INC. | $122.41 | 2019-2025 | Euflexxa |
| Astrazeneca Pharmaceuticals LP | $121.34 | 2023 | Lynparza |
| Bioventus LLC | $101.89 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Gelsyn-3 |
| Medline Industries LP | $88.95 | 2024 | Medline, Medline Industries, INC., Remedy Antifungal |
| Abbvie INC. | $60.00 | 2021-2025 | |
| Misonix INC | $50.43 | 2021 | |
| Pacira Therapeutics, INC. | $49.79 | 2019-2020 | |
| Orthofix Medical, INC. | $48.62 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $47.17 | 2024 | Iovera, Zilretta, Exparel |
| Acera Surgical, INC. | $18.90 | 2021 | |
| Bsn Medical INC | $16.60 | 2019 | |
| Polynovo North America LLC | $16.05 | 2025 | Novosorb Btm |
| Melinta Therapeutics, LLC | $15.07 | 2021 | |
| Tenex Health INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daria Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.